LAMEA Facial Injectable Market Size, Share & Industry Trends Analysis Report By End-use (MedSpa, Dermatology Clinics and Hospitals), By Product, By Application, By Country and Growth Forecast, 2023 - 2029

The Latin America, Middle East and Africa Facial Injectable Market would witness market growth of 16.5% CAGR during the forecast period (2023-2029).

The most common procedures use fillers because the risk involved in this type of treatment is quite low. In addition, because fillers like hyaluronic acid and poly-L lactic acid are readily accepted by the body, there can be few allergic responses. In comparison to invasive surgeries, minimally invasive procedures include benefits like shorter hospital stays, smaller incisions, quick outpatient services, quick wound healing, less pain, and a lower chance of complications. As a result, over the projection period, there will likely be a rise in demand for facial injectables.

Cosmetic-grade HA has a low molecular weight that enables deep epidermal penetration of the substance, aiding in water retention in the cells and releasing antioxidants that slow the aging process. In addition to acting as a moisturizer, HA treats burns, skin ulcers, and wounds. In plastic surgery, HA is also applied to the lips as a filler. The increased usage of HA in cosmetic products or as a dermal filler is predicted to support market expansion.

A wide variety of ethnic groups make up the population of the United Arab Emirates (UAE). The UAE is thought to have the third-highest number of patients in the Middle East seeking cosmetic surgery, behind Saudi Arabia and Egypt. Dubai has been identified as the medical aesthetics hub of the Middle East, boasting 276 facilities, 386 board-certified dermatologists, and 236 certified cosmetic surgeons. The demand for cosmetic procedures in the UAE has been increasing as cosmetic surgery ranks among the top five medical tourism treatments. The aesthetics industry is one of the key factors influencing medical tourism to the UAE. Both a significant increase in regional patients and a surge in regionally based, globally qualified businesses may be responsible for this. Due to this, many aesthetic procedures are carried out in the region, which assists in the expansion of the regional market.

The Brazil market dominated the LAMEA Facial Injectable Market by Country in 2022 thereby, achieving a market value of $490.2 Million by 2029. The Argentina market is experiencing a CAGR of 17.1% during (2023 - 2029). Additionally, The UAE market would exhibit a CAGR of 16.2% during (2023 - 2029).

Based on End-use, the market is segmented into MedSpa, Dermatology Clinics and Hospitals. Based on Product, the market is segmented into Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), Poly-L-Lactic Acid (PLLA), Collagen & PMMA Microspheres, Hyaluronic Acid (HA) and Others. Based on Application, the market is segmented into Facial Line Correction, Face Lift, Lip Augmentation, Acne Scar Treatment, Lipoatrophy Treatment and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Worldwide Facial Injectable Market is Projected to reach USD 22.5 Billion by 2029, at a CAGR of 10.1%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Ipsen Pharma Biotech SAS, Merz Pharma GmbH & Co. KGaA, Suneva Medical, Inc., Medytox Inc., Sinclair Pharma Ltd., Bloomage Biotechnology Corporation Limited (Bloomage International Investment Group), Anika Therapeutics, Inc., Prollenium Medical Technologies Inc., Galderma S.A., and Allergan PLC (AbbVie, Inc.).

Scope of the Study

Market Segments Covered in the Report:

By End-use

• MedSpa
• Dermatology Clinics
• Hospitals

By Product

• Botulinum Toxin Type A
• Calcium Hydroxylapatite (CaHA)
• Poly-L-Lactic Acid (PLLA)
• Collagen & PMMA Microspheres
• Hyaluronic Acid (HA)
• Others

By Application

• Facial Line Correction
• Face Lift
• Lip Augmentation
• Acne Scar Treatment
• Lipoatrophy Treatment
• Others

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Ipsen Pharma Biotech SAS
• Merz Pharma GmbH & Co. KGaA
• Suneva Medical, Inc.
• Medytox Inc.
• Sinclair Pharma Ltd.
• Bloomage Biotechnology Corporation Limited (Bloomage International Investment Group)
• Anika Therapeutics, Inc.
• Prollenium Medical Technologies Inc.
• Galderma S.A.
• Allergan PLC (AbbVie, Inc.)

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Facial Injectable Market, by End-use
1.4.2 LAMEA Facial Injectable Market, by Product
1.4.3 LAMEA Facial Injectable Market, by Application
1.4.4 LAMEA Facial Injectable Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. LAMEA Facial Injectable Market by End-use
3.1 LAMEA MedSpa Market by Country
3.2 LAMEA Dermatology Clinics Market by Country
3.3 LAMEA Hospitals Market by Country

Chapter 4. LAMEA Facial Injectable Market by Product
4.1 LAMEA Botulinum Toxin Type A Market by Country
4.2 LAMEA Calcium Hydroxylapatite (CaHA) Market by Country
4.3 LAMEA Poly-L-Lactic Acid (PLLA) Market by Country
4.4 LAMEA Collagen & PMMA Microspheres Market by Country
4.5 LAMEA Hyaluronic Acid (HA) Market by Country
4.6 LAMEA Others Market by Country

Chapter 5. LAMEA Facial Injectable Market by Application
5.1 LAMEA Facial Line Correction Market by Country
5.2 LAMEA Face Lift Market by Country
5.3 LAMEA Lip Augmentation Market by Country
5.4 LAMEA Acne Scar Treatment Market by Country
5.5 LAMEA Lipoatrophy Treatment Market by Country
5.6 LAMEA Others Market by Country

Chapter 6. LAMEA Facial Injectable Market by Country
6.1 Brazil Facial Injectable Market
6.1.1 Brazil Facial Injectable Market by End-use
6.1.2 Brazil Facial Injectable Market by Product
6.1.3 Brazil Facial Injectable Market by Application
6.2 Argentina Facial Injectable Market
6.2.1 Argentina Facial Injectable Market by End-use
6.2.2 Argentina Facial Injectable Market by Product
6.2.3 Argentina Facial Injectable Market by Application
6.3 UAE Facial Injectable Market
6.3.1 UAE Facial Injectable Market by End-use
6.3.2 UAE Facial Injectable Market by Product
6.3.3 UAE Facial Injectable Market by Application
6.4 Saudi Arabia Facial Injectable Market
6.4.1 Saudi Arabia Facial Injectable Market by End-use
6.4.2 Saudi Arabia Facial Injectable Market by Product
6.4.3 Saudi Arabia Facial Injectable Market by Application
6.5 South Africa Facial Injectable Market
6.5.1 South Africa Facial Injectable Market by End-use
6.5.2 South Africa Facial Injectable Market by Product
6.5.3 South Africa Facial Injectable Market by Application
6.6 Nigeria Facial Injectable Market
6.6.1 Nigeria Facial Injectable Market by End-use
6.6.2 Nigeria Facial Injectable Market by Product
6.6.3 Nigeria Facial Injectable Market by Application
6.7 Rest of LAMEA Facial Injectable Market
6.7.1 Rest of LAMEA Facial Injectable Market by End-use
6.7.2 Rest of LAMEA Facial Injectable Market by Product
6.7.3 Rest of LAMEA Facial Injectable Market by Application

Chapter 7. Company Profiles
7.1 Ipsen Pharma Biotech SAS
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expense
7.2 Merz Pharma GmbH & Co. KGaA
7.2.1 Company Overview
7.2.2 Recent strategies and developments:
7.2.2.1 Partnerships, Collaborations, and Agreements:
7.2.2.2 Product Launches and Product Expansions:
7.3 Suneva Medical, Inc.
7.3.1 Company Overview
7.4 Medytox Inc.
7.4.1 Company Overview
7.5 Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Product Launches and Product Expansions:
7.5.2.2 Approvals and Trials:
7.6 Bloomage Biotechnology Corporation Limited (Bloomage International Investment Group)
7.6.1 Company Overview
7.7 Anika Therapeutics, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expenses
7.8 Prollenium Medical Technologies Inc.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Acquisition and Mergers:
7.9 Galderma S.A.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Partnerships, Collaborations, and Agreements:
7.9.2.2 Acquisition and Mergers:
7.10. Allergan PLC (AbbVie, Inc.)
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional Analysis
7.10.4 Research & Development Expense

TABLE 1 LAMEA Facial Injectable Market, 2019 - 2022, USD Million
TABLE 2 LAMEA Facial Injectable Market, 2023 - 2029, USD Million
TABLE 3 LAMEA Facial Injectable Market by End-use, 2019 - 2022, USD Million
TABLE 4 LAMEA Facial Injectable Market by End-use, 2023 - 2029, USD Million
TABLE 5 LAMEA MedSpa Market by Country, 2019 - 2022, USD Million
TABLE 6 LAMEA MedSpa Market by Country, 2023 - 2029, USD Million
TABLE 7 LAMEA Dermatology Clinics Market by Country, 2019 - 2022, USD Million
TABLE 8 LAMEA Dermatology Clinics Market by Country, 2023 - 2029, USD Million
TABLE 9 LAMEA Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 10 LAMEA Hospitals Market by Country, 2023 - 2029, USD Million
TABLE 11 LAMEA Facial Injectable Market by Product, 2019 - 2022, USD Million
TABLE 12 LAMEA Facial Injectable Market by Product, 2023 - 2029, USD Million
TABLE 13 LAMEA Botulinum Toxin Type A Market by Country, 2019 - 2022, USD Million
TABLE 14 LAMEA Botulinum Toxin Type A Market by Country, 2023 - 2029, USD Million
TABLE 15 LAMEA Calcium Hydroxylapatite (CaHA) Market by Country, 2019 - 2022, USD Million
TABLE 16 LAMEA Calcium Hydroxylapatite (CaHA) Market by Country, 2023 - 2029, USD Million
TABLE 17 LAMEA Poly-L-Lactic Acid (PLLA) Market by Country, 2019 - 2022, USD Million
TABLE 18 LAMEA Poly-L-Lactic Acid (PLLA) Market by Country, 2023 - 2029, USD Million
TABLE 19 LAMEA Collagen & PMMA Microspheres Market by Country, 2019 - 2022, USD Million
TABLE 20 LAMEA Collagen & PMMA Microspheres Market by Country, 2023 - 2029, USD Million
TABLE 21 LAMEA Hyaluronic Acid (HA) Market by Country, 2019 - 2022, USD Million
TABLE 22 LAMEA Hyaluronic Acid (HA) Market by Country, 2023 - 2029, USD Million
TABLE 23 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 24 LAMEA Others Market by Country, 2023 - 2029, USD Million
TABLE 25 LAMEA Facial Injectable Market by Application, 2019 - 2022, USD Million
TABLE 26 LAMEA Facial Injectable Market by Application, 2023 - 2029, USD Million
TABLE 27 LAMEA Facial Line Correction Market by Country, 2019 - 2022, USD Million
TABLE 28 LAMEA Facial Line Correction Market by Country, 2023 - 2029, USD Million
TABLE 29 LAMEA Face Lift Market by Country, 2019 - 2022, USD Million
TABLE 30 LAMEA Face Lift Market by Country, 2023 - 2029, USD Million
TABLE 31 LAMEA Lip Augmentation Market by Country, 2019 - 2022, USD Million
TABLE 32 LAMEA Lip Augmentation Market by Country, 2023 - 2029, USD Million
TABLE 33 LAMEA Acne Scar Treatment Market by Country, 2019 - 2022, USD Million
TABLE 34 LAMEA Acne Scar Treatment Market by Country, 2023 - 2029, USD Million
TABLE 35 LAMEA Lipoatrophy Treatment Market by Country, 2019 - 2022, USD Million
TABLE 36 LAMEA Lipoatrophy Treatment Market by Country, 2023 - 2029, USD Million
TABLE 37 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 38 LAMEA Others Market by Country, 2023 - 2029, USD Million
TABLE 39 LAMEA Facial Injectable Market by Country, 2019 - 2022, USD Million
TABLE 40 LAMEA Facial Injectable Market by Country, 2023 - 2029, USD Million
TABLE 41 Brazil Facial Injectable Market, 2019 - 2022, USD Million
TABLE 42 Brazil Facial Injectable Market, 2023 - 2029, USD Million
TABLE 43 Brazil Facial Injectable Market by End-use, 2019 - 2022, USD Million
TABLE 44 Brazil Facial Injectable Market by End-use, 2023 - 2029, USD Million
TABLE 45 Brazil Facial Injectable Market by Product, 2019 - 2022, USD Million
TABLE 46 Brazil Facial Injectable Market by Product, 2023 - 2029, USD Million
TABLE 47 Brazil Facial Injectable Market by Application, 2019 - 2022, USD Million
TABLE 48 Brazil Facial Injectable Market by Application, 2023 - 2029, USD Million
TABLE 49 Argentina Facial Injectable Market, 2019 - 2022, USD Million
TABLE 50 Argentina Facial Injectable Market, 2023 - 2029, USD Million
TABLE 51 Argentina Facial Injectable Market by End-use, 2019 - 2022, USD Million
TABLE 52 Argentina Facial Injectable Market by End-use, 2023 - 2029, USD Million
TABLE 53 Argentina Facial Injectable Market by Product, 2019 - 2022, USD Million
TABLE 54 Argentina Facial Injectable Market by Product, 2023 - 2029, USD Million
TABLE 55 Argentina Facial Injectable Market by Application, 2019 - 2022, USD Million
TABLE 56 Argentina Facial Injectable Market by Application, 2023 - 2029, USD Million
TABLE 57 UAE Facial Injectable Market, 2019 - 2022, USD Million
TABLE 58 UAE Facial Injectable Market, 2023 - 2029, USD Million
TABLE 59 UAE Facial Injectable Market by End-use, 2019 - 2022, USD Million
TABLE 60 UAE Facial Injectable Market by End-use, 2023 - 2029, USD Million
TABLE 61 UAE Facial Injectable Market by Product, 2019 - 2022, USD Million
TABLE 62 UAE Facial Injectable Market by Product, 2023 - 2029, USD Million
TABLE 63 UAE Facial Injectable Market by Application, 2019 - 2022, USD Million
TABLE 64 UAE Facial Injectable Market by Application, 2023 - 2029, USD Million
TABLE 65 Saudi Arabia Facial Injectable Market, 2019 - 2022, USD Million
TABLE 66 Saudi Arabia Facial Injectable Market, 2023 - 2029, USD Million
TABLE 67 Saudi Arabia Facial Injectable Market by End-use, 2019 - 2022, USD Million
TABLE 68 Saudi Arabia Facial Injectable Market by End-use, 2023 - 2029, USD Million
TABLE 69 Saudi Arabia Facial Injectable Market by Product, 2019 - 2022, USD Million
TABLE 70 Saudi Arabia Facial Injectable Market by Product, 2023 - 2029, USD Million
TABLE 71 Saudi Arabia Facial Injectable Market by Application, 2019 - 2022, USD Million
TABLE 72 Saudi Arabia Facial Injectable Market by Application, 2023 - 2029, USD Million
TABLE 73 South Africa Facial Injectable Market, 2019 - 2022, USD Million
TABLE 74 South Africa Facial Injectable Market, 2023 - 2029, USD Million
TABLE 75 South Africa Facial Injectable Market by End-use, 2019 - 2022, USD Million
TABLE 76 South Africa Facial Injectable Market by End-use, 2023 - 2029, USD Million
TABLE 77 South Africa Facial Injectable Market by Product, 2019 - 2022, USD Million
TABLE 78 South Africa Facial Injectable Market by Product, 2023 - 2029, USD Million
TABLE 79 South Africa Facial Injectable Market by Application, 2019 - 2022, USD Million
TABLE 80 South Africa Facial Injectable Market by Application, 2023 - 2029, USD Million
TABLE 81 Nigeria Facial Injectable Market, 2019 - 2022, USD Million
TABLE 82 Nigeria Facial Injectable Market, 2023 - 2029, USD Million
TABLE 83 Nigeria Facial Injectable Market by End-use, 2019 - 2022, USD Million
TABLE 84 Nigeria Facial Injectable Market by End-use, 2023 - 2029, USD Million
TABLE 85 Nigeria Facial Injectable Market by Product, 2019 - 2022, USD Million
TABLE 86 Nigeria Facial Injectable Market by Product, 2023 - 2029, USD Million
TABLE 87 Nigeria Facial Injectable Market by Application, 2019 - 2022, USD Million
TABLE 88 Nigeria Facial Injectable Market by Application, 2023 - 2029, USD Million
TABLE 89 Rest of LAMEA Facial Injectable Market, 2019 - 2022, USD Million
TABLE 90 Rest of LAMEA Facial Injectable Market, 2023 - 2029, USD Million
TABLE 91 Rest of LAMEA Facial Injectable Market by End-use, 2019 - 2022, USD Million
TABLE 92 Rest of LAMEA Facial Injectable Market by End-use, 2023 - 2029, USD Million
TABLE 93 Rest of LAMEA Facial Injectable Market by Product, 2019 - 2022, USD Million
TABLE 94 Rest of LAMEA Facial Injectable Market by Product, 2023 - 2029, USD Million
TABLE 95 Rest of LAMEA Facial Injectable Market by Application, 2019 - 2022, USD Million
TABLE 96 Rest of LAMEA Facial Injectable Market by Application, 2023 - 2029, USD Million
TABLE 97 Key Information – Ipsen Pharma Biotech SAS
TABLE 98 Key information – Merz Pharma GmbH & Co. KGaA
TABLE 99 Key Information – Suneva Medical, Inc.
TABLE 100 Key Information – Medytox Inc.
TABLE 101 Key Information – Sinclair Pharma Ltd.
TABLE 102 Key Information – Bloomage Biotechnology Corporation Limited
TABLE 103 Key Information – Anika Therapeutics, Inc.
TABLE 104 Key Information – Prollenium Medical Technologies Inc.
TABLE 105 Key Information – Galderma S.A.
TABLE 106 Key Information – Allergan PLC

List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA Facial Injectable Market Share by End-use, 2022
FIG 3 LAMEA Facial Injectable Market Share by End-use, 2029
FIG 4 LAMEA Facial Injectable Market by End-use, 2019 - 2029, USD Million
FIG 5 LAMEA Facial Injectable Market Share by Product, 2022
FIG 6 LAMEA Facial Injectable Market Share by Product, 2029
FIG 7 LAMEA Facial Injectable Market by Product, 2019 - 2029, USD Million
FIG 8 LAMEA Facial Injectable Market Share by Application, 2022
FIG 9 LAMEA Facial Injectable Market Share by Application, 2029
FIG 10 LAMEA Facial Injectable Market by Application, 2019 - 2029, USD Million
FIG 11 LAMEA Facial Injectable Market Share by Country, 2022
FIG 12 LAMEA Facial Injectable Market Share by Country, 2029
FIG 13 LAMEA Facial Injectable Market by Country, 2019 - 2029, USD Million
FIG 14 Recent strategies and developments: Merz Pharma GmbH & Co. KGaA